We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

151 hedge funds and large institutions have $1.66B invested in DIPLOMAT PHARMACY, INC. in 2015 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 66 increasing their positions, 30 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more call options, than puts

Call options by funds: $8.11M | Put options by funds: $2.84M

120% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 30

95% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 22

50% more capital invested

Capital invested by funds: $1.1B → $1.66B (+$555M)

16% more funds holding

Funds holding: 130151 (+21)

Holders
151
Holders Change
+21
Holders Change %
+16.15%
% of All Funds
3.96%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
43
Increased
66
Reduced
30
Closed
22
Calls
$8.11M
Puts
$2.84M
Net Calls
+$5.27M
Net Calls Change
+$3.15M
Name Holding Trade Value Shares
Change
Change in
Stake
SGA
76
Siguler Guff Advisers
New York
$1.29M +$1.18M +37,814 New
SPC
77
Sigma Planning Corp
Michigan
$1.28M +$289K +9,277 +33%
Goldman Sachs
78
Goldman Sachs
New York
$1.28M -$193K -6,199 -14%
RhumbLine Advisers
79
RhumbLine Advisers
Massachusetts
$1.22M +$111K +3,550 +11%
Kayne Anderson Rudnick Investment Management
80
Kayne Anderson Rudnick Investment Management
California
$1.17M +$1.06M +34,030 New
SS
81
Simplicity Solutions
Minnesota
$1.13M +$1.03M +33,005 New
CIA
82
Capital Impact Advisors
Massachusetts
$1.12M
CS
83
Credit Suisse
Switzerland
$1.09M -$103K -3,309 -9%
TA
84
Teton Advisors
New York
$1.02M +$934K +29,950 New
UBS Group
85
UBS Group
Switzerland
$996K +$52.7K +1,688 +6%
LCG
86
Lisanti Capital Growth
New York
$987K +$420K +13,454 +87%
RJA
87
Raymond James & Associates
Florida
$898K -$1.59K -51 -0.2%
MLICM
88
Metropolitan Life Insurance Company (MetLife)
New York
$875K
GC
89
Globeflex Capital
California
$828K +$755K +24,205 New
Mirae Asset Global Investments
90
Mirae Asset Global Investments
South Korea
$825K +$752K +24,102 New
AIG
91
American International Group
New York
$732K -$1.15K -37 -0.2%
PAM
92
Paradigm Asset Management
New York
$698K -$1.04M -33,300 -62%
AQR Capital Management
93
AQR Capital Management
Connecticut
$691K +$630K +20,194 New
State Board of Administration of Florida Retirement System
94
State Board of Administration of Florida Retirement System
Florida
$688K +$75.8K +2,431 +14%
EIM
95
Essex Investment Management
Massachusetts
$608K +$554K +17,767 New
Tudor Investment Corp
96
Tudor Investment Corp
Connecticut
$565K -$234K -7,501 -31%
BG
97
BlackRock Group
United Kingdom
$556K -$7.89K -253 -2%
VOYA Investment Management
98
VOYA Investment Management
Georgia
$534K
Simplex Trading
99
Simplex Trading
Illinois
$528K +$444K +14,218 +1,161%
BA
100
BlackRock Advisors
Delaware
$527K -$229K -7,329 -32%

DPLO Hedge Fund Activity: Q4 2015 in Review

151 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q4 2015, worth a combined $1.66B — up 50% from $1.1B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new DPLO positions and 22 closed out — a net gain of 21 holders — while 66 added to existing stakes and 30 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $68M. The largest seller was Fidelity Investments, cutting an estimated $59M.

  • 151 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q4 2015, up from 130 in Q3 2015.
  • Funds reported $1.66B of DIPLOMAT PHARMACY, INC. stock for Q4 2015, up 50% quarter-over-quarter.
  • 43 funds opened new DIPLOMAT PHARMACY, INC. positions in Q4 2015 and 22 closed out, a net change of +21 holders.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q4 2015 was Janus Henderson Investors US, an estimated $68M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q4 2015 was Fidelity Investments, an estimated $59M sold.

Based on aggregated 13F filings for Q4 2015.